Helicobacter pylori-Infektion

Literatur

• 1 Warren J R. Unidentified curved bacilli on the gastric epithelium in active chronic gastritis.  Lancet. 1983;  1 1273
• 2 Marshall B. Unidentified curved bacilli on the gastric epithelium in active chronic gastritis.  Lancet. 1983;  1 1273-1275
• 3 NIH Consensus Conference . H. pylori in peptic ulcer disease: NIH Consensus Development Panel on H. pylori in peptic ulcer disease.  JAMA. 1994;  272 65-69
• 4 IARC . H. pylori and gastric cancer.  WHO. 1994; 
• 5 Malfertheiner P, Megraud F, O’Morain C. et al . Current concepts in the management of Helicobacter pylori infection - The Maastricht 2 - 2000 Consensus Report.  Aliment Pharmacol Ther. 2002;  16 167-180
• 6 Moayyedi P, Feltbower R, Brown J. et al . Effect of population screening and treatment for H. pylori on dyspepsia and quality of life in the community: a randomized controlled trial. Leeds HELP Study Group.  Lancet. 2000;  355 1665-1669
• 7 Lassen A T, Pedersen F M, Bytzer P. et al . H. pylori test-and-eradicate versus prompt endoscopy for management of dyspeptic patients: a randomised trial.  Lancet. 2000;  5, 356 455-460
• 8 McColl K E, Murray L S, Gillen D. et al . Randomised trial of endoscopy with testing for H. pylori compared with non-invasive H. pylori-testing alone in the management of dyspepsia.  BMJ. 2002;  27, 324 999-1002
• 9 De Boer W A, Tytgat G N. Search and treat strategy to eliminate H. pylori associated ulcer disease.  Gut. 2001;  48, 4 567-570
• 10 Moayyedi P, Soo S, Decks J. et al . Systematic review and economic evaluation of H. pylori eradication treatment for non-ulcer dyspepsia. Dyspepsia Review Group.  BMJ. 2002;  321 659-664
• 11 Malfertheiner P, Gerards C. H. pylori infection and gastro-oesophageal reflux disease: coincidence or association? Baillieres Best Pract Res Clin.  Gastroenterol. 2000;  14, 5 731-741
• 12 Moayyedi P, Bardhan C, Young L. et al . H. pylori eradication does not exacerbate reflux symptoms in gastroesophageal reflux disease.  Gastro­enterology. 2001;  121, 5 1120-1126
• 13 Schwizer W, Thumshirn M, Dent J. et al . H. pylori and symptomatic relapse of gastro-oesophageal reflux disease: a randomised controlled trial.  Lancet. 2001;  2, 357 1738-1742
• 14 Labenz J, Blum A L, Bayerdörffer E. et al . Curing H. pylori infection in patients with duodenal ulcer may provoke reflux esophagitis.  Gastro­enterology. 1997;  112, 5 1442-1447
• 15 Malfertheiner P, Dent J, Zeijlon L. et al . Impact of H. pylori eradication on heartburn in patients with gastric or duodenal ulcer disease - results from a randomized trial programme.  Aliment Pharmacol Ther. 2002;  16, 8 1431-1442
• 16 Huang J Q, Sridhar S, Hunt R H. Role of H. pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis.  Lancet. 2002;  5, 359 14-22
• 17 Chan F K, Sung J J, Chung S C. et al . Randomised trial of eradication of H. pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers.  Lancet. 1997;  4: 350 975-979
• 18 Chan F K, To K F, Wu J C. et al . Eradication of H. pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial.  Lancet. 2002;  5, 359 9-13
• 19 Hawkey C J, Tulassay Z, Szczepanski L. Randomised controlled trial of H. pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study.  Lancet. 1998;  352 1016-1021
• 20 Chan F K, Chung S C, Suen B Y. et al . Preventing recurrent upper gastrointestinal bleeding in patients with H. pylori infection who are taking low-dose aspirin or naproxen.  N Engl J Med. 2001;  29, 344 967-973
• 21 Lai K C, Lam S K, Chu K M. et al . Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use.  N Engl J Med. 2002;  27, 346 2033-2038
• 22 Lind T, van Veldhuyzen Z anten S, Unge P. et al . Eradication of H. pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH 1 study.  Helicobacter. 1996;  1, 3 138-144
• 23 Lind T, Megraud F, Unge P. et al . The MACH2 study: role of omeprazole in eradication of H. pylori with 1-week triple therapies.  Gastroenterology. 1999;  116, 2 248-253
• 24 Wolle K, Leodolter A, Malfertheiner P. et al . Antibiotic susceptibility of H. pylori in Germany: stable primary resistance from 1995 to 2000.  J Med Microbiol. 2002;  51, 8 705-709
• 25 Malfertheiner P, Schultze V, Giudice D. et al . Phase 1 safety and immunogenicity of a three-component H. pylori vaccine.  Gastroenterology. 2002;  122: 1195
• 26 Malfertheiner P, Megraud F, Michetti P. Graham DY (ed) . The Year in Helicobacter 2000. Price A on behalf of the European Helicobacter Study Group. Helicobacter.  Vol. 7, Suppl. 1